Replies to post #182583 on Biotech Values

[biocqr]

Ebola Victim Thomas Eric Duncan Passes Away -- But Not Because Drugs Failed

http://www.forbes.com/sites/davidkroll/2014/10/08/dallas-ebola-victim-passes-away-no-data-just-sadness/?ss=pharma-healthcare

In the case of Mr. Duncan, he didn’t receive the drug until 19 days after the day he was most likely infected with the virus. All non-human primate work done with any of the experimental treatments from any company have never extended beyond treatment four days post-infection.